Table 4.

Significance Tests for Recurrence Versus Disease-Free Groups on Intercept and Slope Estimates and Their Differences

	Intercept				Slope
Measure	Estimate	SE	t	P	Estimate	SE	t	P
Sexuality
Intercourse frequency
Recurrence	1.59	0.19	8.22	.00	−0.02	0.01	−1.21	.23
Disease free	0.50	0.24	2.13	.03*	0.00	0.01	0.27	.79
Kissing frequency
Recurrence	6.80	0.34	19.92	.00	−0.04	0.03	−1.57	.12
Disease free	−0.81	0.42	−1.95	.053	0.06	0.03	1.83	.07
Sexual satisfaction
Recurrence	3.27	0.25	12.84	.00	−0.01	0.02	−0.36	.72
Disease free	0.26	0.31	0.86	.39	0.02	0.02	0.69	.49
Relationship satisfaction
Recurrence	3.94	0.14	27.41	.00	0.00	0.01	0.31	.76
Disease free	−0.24	0.18	−1.33	.19	−0.02	0.01	−1.36	.18
Cancer-specific stress
IES
Recurrence	19.23	1.70	11.29	.00	−0.36	0.14	−2.68	.01†
Disease free	−7.06	2.09	−3.38	.00*	0.18	0.17	1.09	.28
Physical functioning
SymS/Tox
Recurrence	0.26	0.01	18.51	.00	0.00	0.00	−1.85	.07
Disease free	−0.04	0.02	−2.45	.02*	0.00	0.00	0.84	.40
KPS
Recurrence	80.29	1.01	79.78	.00	0.11	0.13	0.88	.38
Disease free	10.50	1.23	8.56	.00*	−0.18	0.15	−1.18	.24

Abbreviations: IES, impact of events scale; SymS/Tox, symptoms, signs, illnesses, and toxicities; KPS, Karnofsky performance status.

^*Significant group difference at baseline.

^†Significant change over time within recurrence group.